COVID-19: recommendations on use of adapted vaccines

The European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) have issued a joint statement (link) providing updated public health considerations on the use of the newly authorised adapted COVID-19 vaccines to support the planning of the autumn and winter vaccination campaigns.

Lesen Sie weiter auf: COVID-19: recommendations on use of adapted vaccines
Quelle: European Centre for Disease Prevention and Control
Titelbild/Grafik by European Centre for Disease Prevention and Control

Kommentare und Fragen

Möchten Sie zu diesem Artikel ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!

Aktuelles von European Centre for Disease Prevention and Control

• Weekly COVID-19 country overview
• Strengthening the sustainability of MediPIET
• Joint ECDC-WHO/Europe mpox (monkeypox) surveillance bulletin
• Mpox (formerly named monkeypox) situation update, as of 17 January 2023
• ECDC assesses risk to the EU/EEA associated with Omicron XBB1.5 sub-lineage
• Ebola outbreak in Uganda, as of 11 January 2023
• EASA/ECDC provide guidelines for aviation as part of European response to COVID-19 developments in China
• Update on SARS-CoV-2 variants: ECDC assessment of the XBB.1.5 sub-lineage
• Impact of surge in China COVID-19 cases on epidemiological situation in EU/EEA
• The Mediterranean and Black Sea Programme in Intervention Epidemiology Training joins the global Training Programs in Epidemiology and Public Health Interventions network